Mesoblast

Mesoblast EPS

The Earnings per Share (EPS) of Mesoblast (MESO) as of Oct 25, 2026 is -0.04 USD. In the previous year, Earnings per Share (EPS) was -0.79 USD — a change of -94.38% (higher).

EPS

-0.04USD

YoY

-94.38%

Last updated:

Earnings per Share (EPS) of Mesoblast is 2026 -0.04 USD. Earnings per Share (EPS) of Mesoblast was 2025 -0.79 USD. It decreases by -94.38% higher compared to the previous year.

The Mesoblast EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2024
-0.77 USD
Jan 1, 2025
-0.79 USD
Jan 1, 2026
-0.04 USD
Jan 1, 2027 (e)
-0.19 USD
Jan 1, 2028 (e)
0.14 USD
Jan 1, 2029 (e)
1.05 USD
Jan 1, 2030 (e)
3.20 USD
Jan 1, 2031 (e)
5.04 USD
The Mesoblast EPS history
YEAREPSYoY
est5.04USD+57.59%
est3.20USD+203.46%
est1.05USD+640.36%
est0.14USD-173.89%
est-0.19USD+333.50%
-0.04USD-94.38%
-0.79USD+2.67%
-0.77USD-19.94%
-0.96USD-18.88%
-1.19USD-22.24%
-1.52USD+14.70%
-1.33USD-20.90%
-1.68USD+134.15%
-0.72USD-55.96%
-1.63USD+2,022.71%
-0.08USD-96.54%
-2.22USD+47.44%
-1.51USD+31.29%
-1.15USD-13.33%
-1.32USD-178.52%
1.69USD-713.00%
-0.27USD+20.31%
-0.23USD+22.09%
-0.19USD+15.29%
-0.16USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mesoblast Stock analysis

What does Mesoblast do? Mesoblast Ltd, based in Melbourne, Australia, develops regenerative medicine products using mesenchymal lineage cells. The company focuses on clinical-stage therapies such as Remestemcel-L for inflammatory conditions including graft versus host disease and inflammatory bowel disease, and MPC-300-IV for rheumatoid arthritis. It operates in Australia, the US, Singapore, and Switzerland with 81 employees and is listed on the stock exchange since 2015. Mesoblast is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mesoblast stock

Earnings per Share (EPS) of Mesoblast is -0.04 USD in 2026.

Earnings per Share (EPS) of Mesoblast changed from -0.79 USD to -0.04 USD, representing a -94.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Mesoblast since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Mesoblast

All Key Metrics — Mesoblast